Crocs

Andrew Rees sold 30,000 Crocs shares from the Rees Family Living Trust at a weighted average price of $138.49, realising roughly $4.2 million. The sale reduced his indirect holdings by about 4% and represents 2% of his total beneficial ownership, leaving him with approximately 1.3 million shares overall. The transaction follows a period of strong stock appreciation and is described as likely routine diversification rather than market timing. » More on finance.yahoo.com

Crocs shares fell about 10.8% in premarket trading to $119.13 after the release of Q2 results and a cautious outlook. Management expects a slight revenue decline; the Crocs brand is forecast to grow 1–3%, while HEYDUDE is expected to shrink 12–14%, with an adjusted operating margin of 24.7% and adjusted EPS of $4.15–4.35. HEYDUDE is suffering from weak demand, duty costs, wholesale pressure and a protracted realignment involving returns and lower marketing spending. Insider sales of roughly $3.9 million and a significant run-up in the stock before the results intensified the negative market reaction. » More on de.investing.com

Crocs shares rose about 2.4% in midday trading to $136.55 and reached $138.08 intraday, a new 52-week high, as investors built positions ahead of the quarterly report on July 30. The rally is supported by a string of analyst upgrades and price-target increases, including Baird (Jonathan Komp) upgrading to "Outperform" with a $150 target and target raises from BofA Securities and Williams Trading. Reasons cited include a continued recovery in North America, positive trends in the direct-to-consumer business, product improvements and an increased full-year forecast after strong Q1 results. The stock is therefore showing a marked outperformance versus the broader market. » More on de.investing.com